Hanna GJ, Oakley LB, Shi R, ONeill A, et al. Duvelisib with docetaxel for patients with anti-PD-1 refractory, recurrent or metastatic head and neck squamous cell carcinoma. Clin Cancer Res 2024 Dec 3. doi: 10.1158/1078-0432.CCR-24-2262.
PMID: 39625478